Related Experiment Video
Updated: Nov 15, 2025

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Extending and validating the Baveno VI criteria for the exclusion of high-risk varices
Andreea Barbulescu1, Iulia Ratiu2, Ioan Sporea3
1Department of Gastroenterology and Hepatology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania. barbulescu.andra91@gmail.com.
Insights
The Baveno VI guidelines accurately exclude high-risk varices (HRV) in cirrhotic patients. Adding albumin thresholds improves accuracy, potentially eliminating unnecessary esophago-gastro-duodenoscopy (EGD) screenings.
Area of Science:
- Hepatology
- Gastroenterology
- Diagnostic Accuracy
Background:
- Compensated advanced chronic liver disease (cACLD) management guidelines recommend screening for high-risk varices (HRV).
- Esophago-gastro-duodenoscopy (EGD) is the standard for HRV screening but is invasive.
- The Baveno VI guidelines suggest avoiding EGD in cACLD patients with liver stiffness (LSM) <20 kPa and platelet count (PLT) >150,000/L.
Purpose of the Study:
- To validate the extended Baveno VI criteria in a large cohort of patients with chronic liver disease.
- To establish specific cut-off values for liver stiffness and platelet count for HRV screening in the study population.
- To assess the utility of albumin levels in refining HRV risk stratification.
Main Methods:
- Retrospective analysis of 839 patients with liver cirrhosis.
- Evaluation using Transient Elastography (TE), laboratory tests, and upper endoscopy within one year.
- Validation of Baveno VI criteria on a randomly selected cohort (Cohort 1, n=728) and determination of tailored cut-offs, with validation on a separate cohort (Cohort 2, n=111).
Main Results:
- Baveno VI criteria demonstrated 86.2% accuracy in Cohort 1.
- Tailored cut-offs for ruling out HRV were PLT >150,000/mm³ and LSM <19.6 kPa.
- Albumin <3.4 g/dL was independently associated with HRV in the grey-zone. The rule-out criteria achieved 100% accuracy in Cohort 2.
Conclusions:
- The Baveno VI criteria show good accuracy for excluding HRV in cirrhotic patients.
- Incorporating an albumin threshold enhances the performance and applicability of HRV screening criteria.
- Utilizing the derived rule-out criteria can effectively prevent unnecessary EGD procedures.
Aim:
The updated Baveno VI guidelines recommend that screening for high-risk varices (HRV) by esophago-gastro-duodenoscopy (EGD) can be avoided in patients with compensated advanced chronic liver disease (cACLD) who have liver stiffness LSM<20 kPa and platelet count PLT>150,000/L. The aims of this study were to validate extended Baveno VI criteria in patients with chronic liver disease and to establish cut-off values for our cohort.
Materials And Methods:
This retrospective study included 839 patients with liver cirrhosis evaluated by Transient Elastography (TE), biological tests, and upper endos-copy, all within one year. The Baveno VI criteria were validated on a sub-group of 728 patients (Cohort 1, randomly selected from the study sample) and tailored cut-off points were determined. The remaining 111 patients comprised the validating set (Cohort 2) for these specific cut-off values.
Results:
In Cohort 1, Baveno VI criteria had 86.2% accuracy. The calculated cut-offs to rule-in HRV were PLT<150,000/mm3 and LSM >35.3 kPa; while to rule-out HRV they were PLT >150.000/mm3 and LSM <19.6 kPa. In patients in the "grey-zone", by multivariate analysis, albumin was independently associated with HRV at a cut-off of ˂3.4 g/dl. In the validation cohort, the calculated rule out cut-offs had 100% accuracy.
Conclusions:
The Baveno VI criteria had a good accuracy for exclusion of HRV in this large cohort of cirrhotic patients. Adding an albumin-related threshold increased performance and broadened applicability. Using the calculated rule-out criteria for HRV, all unnecessary EGD could be excluded.
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Esophageal Varices-I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins I: Introduction
Venous Thrombosis IV: Nursing Management

